The relationship between CYP1A2 and fertility is not well established in scientific literature. CYP1A2 is an enzyme primarily involved in caffeine metabolism and the breakdown of certain hormones like estrogen. Some studies suggest that genetic variants in CYP1A2 may influence fertility through altered estrogen levels or caffeine sensitivity, but the evidence is weak—mostly mechanistic or from small GWAS. No consumer DNA test (including MyBody-X) is clinically validated to diagnose or treat fertility issues. MyBody-X's Hormon & VitalCheck for women measures biomarkers like TSH, prolactin, and cortisol, which can indirectly relate to fertility, but does not include CYP1A2. For a thorough fertility assessment, medical evaluation and specific hormone tests are essential. The role of CYP1A2 genotyping in fertility remains unclear and not actionable.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-063872f2f587e06beff5d067